Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-08 · accession 0001193125-26-102762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-11 | 2026-03-08+ | TMCI | Treace John T. | CEO, Dir, 10% | F - Tax | $0.00 | -7,083 | 7.01M | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | F | D | 5,021 | $0.00 | 7,004,550 | D | — | — | (F2) Includes 542,784 restricted stock units. |
| 2 | Common | Common Stock | 2026-03-08 | F | D | 2,062 | $0.00 | 7,009,571 | D | — | — | (F1) Includes 563,403 restricted stock units. |